Pharmaceutical

Israeli company bags $4.2m contract to develop cell therapy for radiation poisoning

Pluri signed a 3-year contract to develop cell therapy to treat acute radiation syndrome in collaboration with the US Army.

Jul 11, 2023 - 20:00
Israeli company bags $4.2m contract to develop cell therapy for radiation poisoning
Pluri signed a 3-year contract to develop cell therapy to treat acute radiation syndrome in collaboration with the US Army.
Read the original article

Tags:

Previous Article

Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit

Next Article

Roche’s Columvi receives marketing approval in Europe

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

As she drives research on structural racism in health care, Rachel Hardeman faces a painful reckoning

As she drives research on structural racism in health c...

Jan 12, 2024

Listen: Illumina’s boardroom intrigue, the next big Alzheimer’s readout, & J&J’s creative lawyers

Listen: Illumina’s boardroom intrigue, the next big Alz...

Apr 7, 2023

STAT+: NIH fellows, weighing a union, want a pay raise. Will that mean less money for grants?

STAT+: NIH fellows, weighing a union, want a pay raise....

Jul 12, 2023